BPC
EVFM

Banque Pictet & Cie’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Banque Pictet & Cie’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-121
Closed -$82K – 505
2014
Q4 		$82K Buy
+121
New +$91.4K ﹤0.01% 458

Other funds holding EVFM

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
PSC
Piper Sandler & Co Minneapolis, Minnesota $135M AUM 0.15% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Banque Pictet & Cie's EVFM Position: Q1 2015 in Review

Banque Pictet & Cie sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2015, closing a stake of 121 shares — an estimated $82K sold.

Banque Pictet & Cie first reported a position in EVFM in Q4 2014 and held it in 1 quarter. The position peaked at $82K in Q4 2014. 21 funds tracked by Wall St. Rank hold EVFM as of Q1 2015.

  • Banque Pictet & Cie reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Banque Pictet & Cie sold 121 Evofem Biosciences, Inc. Common Stock shares in Q1 2015, an estimated $82K.
  • Banque Pictet & Cie first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Banque Pictet & Cie's Evofem Biosciences, Inc. Common Stock position peaked at $82K in Q4 2014.
  • 21 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2015.

Based on Banque Pictet & Cie's 13F filing for Q1 2015, filed 8 May 2015.